Skip to content

Net margin at other companies

AbbVie logo
AbbVieABBV
5.8%-1.5pp
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-615.3%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
-174,314.2%-62,763pp
Opko Health logo
Opko HealthOPK
-36.6%-44.8pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
29.6%-2.3pp
Regenxbio logo
RegenxbioRGNX
-330.2%-588pp

Other financials

Income statement

See full
Revenue$2.2M-50.6%
Operating income-$14.4M-44.7%
Net income-$65.5M-700%
EPS (diluted)-$0.75-213%

Balance sheet

See full
Cash & equivalents$60.0M+43.5%
Total debt$1.2M
Total equity-$45.8M-1,004%
Total assets$66.8M+38.7%

Cash flow

See full
Operating cash flow-$12.7M-41.5%

Valuation

See full
Market cap$307.14M+442%
Enterprise value$248.38M
P/S25.6×+21.5×

Profitability

See full
Operating margin-359.1%-68.9pp

Returns & leverage

See full
Return on equity-449.4%-2,573pp
Debt / equity0.1×
Current ratio7.1×+5.2×

Where this comes from

Calculated from Opus Genetics’s reported figures.

Based on trailing twelve months.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opus Genetics's net margin?
Opus Genetics (IRD) reported net margin of -892.4% in Q1 2026.
How has Opus Genetics's net margin changed year-over-year?
Opus Genetics's net margin decreased by 107.8% year-over-year, from -429.4% to -892.4%.
What is the long-term trend for Opus Genetics's net margin?
Over 3 years (2022 to 2025), Opus Genetics's net margin has grown at a 98.2% compound annual growth rate (CAGR), from 44.9% to -349.3%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.